University of California, San Francisco (UCSF) Study Questions Drug Trial Results; When Drug Companies Sponsor Research, Their Products More Likely to Perform Well

Money talks -- and very loudly when a drug company is funding a clinical trial involving one of its products, according to a study released Monday. UCSF researchers looked at nearly 200 head-to-head studies of widely prescribed cholesterol-lowering medications, or statins, and found that results were 20 times more likely to favor the drug made by the company that sponsored the trial.